APEXIGEN INC (APGN) Stock Price, Quote, News and Overview
NASDAQ:APGN - Nasdaq - US03759B1026 - Common Stock - Currency: USD
APGN Quote, Performance and Key Statistics
0.3851
+0.03 (+8.48%)
The current stock price of APGN is 0.3851 USD. In the past month the price decreased by -6.07%. In the past year, price decreased by -92.33%.
APGN Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About APGN
Company Profile
Apexigen, Inc. operates as a clinical-stage biopharmaceutical company. The company is headquartered in San Carlos, California and currently employs 20 full-time employees. The company went IPO on 2021-02-02. The firm is focused on discovering and developing antibody therapeutics for oncology, with an emphasis on new immuno-oncology agents designed to harness the patient’s immune system to combat and eradicate cancer. The company has developed a clinical-stage candidate, namely sotigalimab (sotiga or APX005M), which is a humanized agonist antibody. The company also has various preclinical and research-stage antibodies it discovered using its APXiMAB platform. The company is focused on completing ongoing clinical and manufacturing activities for the sotiga program. The Company’s licensees are advancing five product candidates in clinical development that were enabled by discoveries from its APXiMAB platform. APX005M is under Phase II clinical development for the treatment of solid tumors, such as soft tissue sarcomas, esophageal and gastroesophageal junction cancers and melanoma, in combination with chemotherapy, radiation therapy and immunotherapy.
Company Info
APEXIGEN INC
900 Industrial Road, Suite C
San Carlos CALIFORNIA US
Employees: 20
Company Website: https://www.apexigen.com/
Phone: 16509316236.0
APEXIGEN INC / APGN FAQ
What is the stock price of APEXIGEN INC today?
The current stock price of APGN is 0.3851 USD. The price increased by 8.48% in the last trading session.
What is the ticker symbol for APEXIGEN INC stock?
The exchange symbol of APEXIGEN INC is APGN and it is listed on the Nasdaq exchange.
On which exchange is APGN stock listed?
APGN stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for APEXIGEN INC stock?
6 analysts have analysed APGN and the average price target is 0.65 USD. This implies a price increase of 69.51% is expected in the next year compared to the current price of 0.3851. Check the APEXIGEN INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is APEXIGEN INC worth?
APEXIGEN INC (APGN) has a market capitalization of 9.57M USD. This makes APGN a Nano Cap stock.
How many employees does APEXIGEN INC have?
APEXIGEN INC (APGN) currently has 20 employees.
What are the support and resistance levels for APEXIGEN INC (APGN) stock?
APEXIGEN INC (APGN) has a resistance level at 0.4. Check the full technical report for a detailed analysis of APGN support and resistance levels.
Should I buy APEXIGEN INC (APGN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of APGN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of APGN, evaluating the profitability, health, valuation and growth aspects
- APEXIGEN INC (APGN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- APEXIGEN INC (APGN) Sales and EPS estimates to see what analysts future expectations are.
- APEXIGEN INC (APGN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- APEXIGEN INC (APGN) Insider and Institutional Ownership to learn about the owners and their transactions.
- APEXIGEN INC (APGN) Stock Chart to make your own analysis
- APEXIGEN INC (APGN) Latest news and press-releases to stay up to date.
Does APEXIGEN INC (APGN) stock pay dividends?
APGN does not pay a dividend.
APGN Technical Analysis
APGN Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
APGN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to APGN. The Buy consensus is the average rating of analysts ratings from 6 analysts.